openPR Logo
Press release

Colorectal Cancer Market is projected to exhibit a CAGR of 4.7%, with an estimated worth of US$ 2.88 billion by year 2032 end | PMR

04-08-2024 09:15 AM CET | Health & Medicine

Press release from: Polaris Market Research & Consulting

Colorectal Cancer Market

Colorectal Cancer Market

๐‚๐จ๐ฅ๐จ๐ซ๐ž๐œ๐ญ๐š๐ฅ ๐‚๐š๐ง๐œ๐ž๐ซ ๐Œ๐š๐ซ๐ค๐ž๐ญ

๐€๐œ๐œ๐จ๐ซ๐๐ข๐ง๐  ๐ญ๐จ ๐ญ๐ก๐ž ๐ซ๐ž๐ฌ๐ž๐š๐ซ๐œ๐ก ๐ซ๐ž๐ฉ๐จ๐ซ๐ญ, ๐ญ๐ก๐ž ๐ ๐ฅ๐จ๐›๐š๐ฅ ๐œ๐จ๐ฅ๐จ๐ซ๐ž๐œ๐ญ๐š๐ฅ ๐œ๐š๐ง๐œ๐ž๐ซ ๐ฆ๐š๐ซ๐ค๐ž๐ญ ๐ฐ๐š๐ฌ ๐ฏ๐š๐ฅ๐ฎ๐ž๐ ๐š๐ญ ๐”๐’๐ƒ ๐Ÿ.๐Ÿ—๐ŸŽ ๐›๐ข๐ฅ๐ฅ๐ข๐จ๐ง ๐ข๐ง ๐Ÿ๐ŸŽ๐Ÿ๐Ÿ‘ ๐š๐ง๐ ๐ข๐ฌ ๐ž๐ฑ๐ฉ๐ž๐œ๐ญ๐ž๐ ๐ญ๐จ ๐ซ๐ž๐š๐œ๐ก ๐”๐’๐ƒ ๐Ÿ.๐Ÿ–๐Ÿ– ๐›๐ข๐ฅ๐ฅ๐ข๐จ๐ง ๐›๐ฒ ๐Ÿ๐ŸŽ๐Ÿ‘๐Ÿ, ๐ญ๐จ ๐ ๐ซ๐จ๐ฐ ๐š๐ญ ๐š ๐‚๐€๐†๐‘ ๐จ๐Ÿ ๐Ÿ’.๐Ÿ–๐ŸŽ% ๐๐ฎ๐ซ๐ข๐ง๐  ๐ญ๐ก๐ž ๐Ÿ๐จ๐ซ๐ž๐œ๐š๐ฌ๐ญ ๐ฉ๐ž๐ซ๐ข๐จ๐.

Colorectal cancer, also known as colon cancer, is cancer which begins in the alimentary or colon. The bowel and colon have the function of supporting the digestive functioning of the body. As a U-shaped tube made of muscle and found below the stomach, the colon is responsible for absorbing water and some food nutrients. The celiac, which is at the end of your colon and on the other side of the anal canal, is where the body stores stool. Colon cancer arises when there are changes in the genetic material (DNA). Usually, the changes in DNA that can lead to colon cancer happen during the lifetime. Along with genetics, other factors that may contribute to colon cancer are the lifestyle and the environment.

๐€๐ฌ๐ค ๐”๐ฌ ๐ญ๐จ ๐†๐ž๐ญ ๐˜๐จ๐ฎ๐ซ ๐’๐š๐ฆ๐ฉ๐ฅ๐ž ๐๐ƒ๐… ๐‘๐ž๐ฉ๐จ๐ซ๐ญ : https://www.polarismarketresearch.com/industry-analysis/global-colorectal-cancer-market/request-for-sample

The common symptoms of colon cancer include blood in the stool, persistent changes in bowel habits, abdominal pain, bloated stomach, and unexplained weight loss. The treatment for colon cancer takes the form of radiation therapy, targeted therapy, chemotherapy, and immunotherapy. Other treatment options include surgery and embolization. The rising prevalence of cancer cases worldwide is one of the primary factors propelling the colorectal cancer market demand.

๐Š๐ž๐ฒ ๐ˆ๐ง๐๐ฎ๐ฌ๐ญ๐ซ๐ฒ ๐๐š๐ซ๐ญ๐ข๐œ๐ข๐ฉ๐š๐ง๐ญ๐ฌ
Some of the major players operating in the global market are:
โ€ข Amgen Inc
โ€ข Epigenomics AG
โ€ข Bruker Corporation
โ€ข Clinical Genomics Technologies Pty Ltd.
โ€ข F. Hoffmann-La Roche AG
โ€ข VolitionRx Limited
โ€ข Abbott
โ€ข Novigenix SA
โ€ข Quest Diagnostics
โ€ข EDP Biotech

๐๐ฎ๐ฒ ๐ญ๐ก๐ข๐ฌ ๐๐ซ๐ž๐ฆ๐ข๐ฎ๐ฆ ๐‘๐ž๐ฌ๐ž๐š๐ซ๐œ๐ก ๐‘๐ž๐ฉ๐จ๐ซ๐ญ: https://www.polarismarketresearch.com/buy/1979/2

๐’๐ž๐ ๐ฆ๐ž๐ง๐ญ๐š๐ฅ ๐Ž๐ฏ๐ž๐ซ๐ฏ๐ข๐ž๐ฐ
๐๐ฒ ๐“๐ซ๐ž๐š๐ญ๐ฆ๐ž๐ง๐ญ :
โ€ข Radiation Therapy
โ€ข Targeted therapy
โ€ข Chemotherapy
โ€ข Immunotherapy
โ€ข Surgery
โ€ข Embolization
โ€ข Others
๐๐ฒ ๐„๐ง๐-๐”๐ฌ๐ž :
โ€ข Hospitals
โ€ข Specialty Clinics
โ€ข Diagnostic & Research Laboratories

๐‘๐ž๐ ๐ข๐จ๐ง๐š๐ฅ ๐ˆ๐ง๐ฌ๐ข๐ ๐ก๐ญ๐ฌ
North America (U.S., Canada)
โ€ข Europe (France, Germany, UK, Italy, Netherlands, Spain, Russia)
โ€ข Asia Pacific (Japan, China, India, Malaysia, Indonesia. South Korea)
โ€ข Latin America (Brazil, Mexico, Argentina)
โ€ข Middle East & Africa (Saudi Arabia, UAE, Israel, South Africa)

๐๐ซ๐จ๐ฐ๐ฌ๐ž ๐€๐๐๐ข๐ญ๐ข๐จ๐ง๐š๐ฅ ๐ƒ๐ž๐ญ๐š๐ข๐ฅ๐ฌ : https://www.polarismarketresearch.com/industry-analysis/global-colorectal-cancer-market

Colorectal Cancer Market Report Highlights
โ€ข Targeted therapy has become prominent due to the crucial life-preserving activities that this section performs
โ€ข Diagnostic & Research Laboratories are anticipated to grow significantly, especially in emerging nations due to the rising affordability of diagnostic technology and tools.
โ€ข North America had the greatest share, and it is expected to continue to lead because of the rising illness burden, rising treatment rates, and expensive prescription prices.
โ€ข The global key market players include F. Hoffmann-La Roche AG, VolitionRx Limited, Abbott, Novigenix SA, Quest Diagnostics, and EDP Biotech.

๐‘๐ž๐ฅ๐š๐ญ๐ž๐ ๐‘๐ž๐ฉ๐จ๐ซ๐ญ๐ฌ :

๐—–๐—ฒ๐—น๐—น ๐—œ๐˜€๐—ผ๐—น๐—ฎ๐˜๐—ถ๐—ผ๐—ป/๐—–๐—ฒ๐—น๐—น ๐—ฆ๐—ฒ๐—ฝ๐—ฎ๐—ฟ๐—ฎ๐˜๐—ถ๐—ผ๐—ป ๐— ๐—ฎ๐—ฟ๐—ธ๐—ฒ๐˜ : https://www.polarismarketresearch.com/industry-analysis/global-cell-isolation-cell-separation-market
๐—œ๐—ผ๐—ง ๐— ๐—ฒ๐—ฑ๐—ถ๐—ฐ๐—ฎ๐—น ๐——๐—ฒ๐˜ƒ๐—ถ๐—ฐ๐—ฒ๐˜€ ๐— ๐—ฎ๐—ฟ๐—ธ๐—ฒ๐˜ : https://www.polarismarketresearch.com/industry-analysis/iot-medical-devices-market
๐—ฅ๐—ฒ๐˜€๐—ฝ๐—ถ๐—ฟ๐—ฎ๐˜๐—ผ๐—ฟ๐˜† ๐—–๐—ฎ๐—ฟ๐—ฒ ๐——๐—ฒ๐˜ƒ๐—ถ๐—ฐ๐—ฒ๐˜€ ๐— ๐—ฎ๐—ฟ๐—ธ๐—ฒ๐˜: https://www.polarismarketresearch.com/industry-analysis/respiratory-care-devices-market
๐—ฃ๐—ต๐—ฎ๐—ฟ๐—บ๐—ฎ๐—ฐ๐—ฒ๐˜‚๐˜๐—ถ๐—ฐ๐—ฎ๐—น ๐—˜๐˜…๐—ฐ๐—ถ๐—ฝ๐—ถ๐—ฒ๐—ป๐˜๐˜€ ๐— ๐—ฎ๐—ฟ๐—ธ๐—ฒ๐˜ : https://www.polarismarketresearch.com/industry-analysis/pharmaceutical-excipients-market
๐—ง๐—ถ๐˜€๐˜€๐˜‚๐—ฒ ๐——๐—ถ๐—ฎ๐—ด๐—ป๐—ผ๐˜€๐˜๐—ถ๐—ฐ๐˜€ ๐— ๐—ฎ๐—ฟ๐—ธ๐—ฒ๐˜ : https://www.polarismarketresearch.com/industry-analysis/tissue-diagnostics-market

๐‚๐จ๐ง๐ญ๐š๐œ๐ญ ๐”๐ฌ:
Polaris Market Research
Phone: +1-929-297-9727
Email: sales@polarismarketresearch.com

๐€๐›๐จ๐ฎ๐ญ ๐”๐ฌ:
Polaris Market Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Polaris Market Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We at Polaris are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semi-conductors, chemicals, automotive, and aerospace & defence, among different ventures present globally.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Colorectal Cancer Market is projected to exhibit a CAGR of 4.7%, with an estimated worth of US$ 2.88 billion by year 2032 end | PMR here

News-ID: 3455200 • Views: โ€ฆ

More Releases from Polaris Market Research & Consulting

Granite Market Projected to Reach USD 6.63 Billion by 2034, Growing at a CAGR of 5.2%
Granite Market Projected to Reach USD 6.63 Billion by 2034, Growing at a CAGR of โ€ฆ
Polaris Market Research has released new insights into the Granite market, highlighting key developments, evolving trends, and growth prospects across major regions and segments. The report delivers an in-depth analysis of market dynamics, competitive shifts, and strategic outlooks to support informed decision-making for businesses and investors. Market at a Glance In 2024, the market was valued at USD 3.99 billion and is anticipated to grow to USD 6.63 Billion by 2034. Itโ€ฆ
Molecular Diagnostics for Sexually Transmitted Diseases Market to Reach USD 7.85 Billion by 2034, Growing at a CAGR of 7.5%
Molecular Diagnostics for Sexually Transmitted Diseases Market to Reach USD 7.85 โ€ฆ
Polaris Market Research announces the release of its latest study on the Molecular Diagnostics For Sexually Transmitted Diseases market. It offers comprehensive insights into all the key market aspects, including industry trends, market dynamics, competitive landscape, and strategic developments. The report is designed to help stakeholders make strategic decisions in the rapidly evolving market landscape. According to the findings, the market stood at 3.82 billion in 2024 and is expected toโ€ฆ
Higher Alpha Olefins Market Projected to Hit USD 20.01 Billion by 2034, Expanding at a CAGR of 6.8%
Higher Alpha Olefins Market Projected to Hit USD 20.01 Billion by 2034, Expandin โ€ฆ
Polaris Market Research announces the release of its latest study on the Higher Alpha Olefins market. It offers comprehensive insights into all the key market aspects, including industry trends, market dynamics, competitive landscape, and strategic developments. The report is designed to help stakeholders make strategic decisions in the rapidly evolving market landscape. According to the findings, the market stood at 10.39 billion in 2024 and is expected to reach 20.01 billionโ€ฆ
Direct Oral Anticoagulants (DOACs) Device Market to Reach USD 64.83 Billion by 2034, Growing at a CAGR of 7.44%
Direct Oral Anticoagulants (DOACs) Device Market to Reach USD 64.83 Billion by 2 โ€ฆ
Polaris Market Research announces the release of its latest study on the Direct Oral Anticoagulants (DOACs) Device market. It offers comprehensive insights into all the key market aspects, including industry trends, market dynamics, competitive landscape, and strategic developments. The report is designed to help stakeholders make strategic decisions in the rapidly evolving market landscape. According to the findings, the market stood at 31.67 billion in 2024 and is expected to reachโ€ฆ

All 5 Releases


More Releases for Colorectal

Metastatic Colorectal Cancer Therapeutics Market - Innovation in Motion: Elevate โ€ฆ
Newark, New Castle, USA: The "Metastatic Colorectal Cancer Therapeutics Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors. Metastatic Colorectal Cancer Therapeutics Market: https://www.growthplusreports.com/report/metastatic-colorectal-cancer-therapeutics-market/8685 This latest report researches theโ€ฆ
Potential Opportunities of Colorectal Cancer Therapeutics Market
The global colorectal cancer therapeutics market size is projected to reach USD 16.58 billion by 2026, owing to the rise in the prevalence of colorectal cancer worldwide. A report by Fortune Business Insights(TM) titled, "Colorectal Cancer Therapeutics Market Size, Share & Industry Analysis, By Therapy (Targeted Therapy, Immunotherapy, Chemotherapy, Others), By Cancer Type (Colorectal Adenocarcinoma, Gastrointestinal Carcinoid Tumors, Others), By Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies, Others) andโ€ฆ
Colorectal Cancer Pipeline Therapeutic Review H1 2017
Colorectal Cancer Pipeline Review H1 2017 provides an overview of the Colorectal Cancer (Oncology) pipeline landscape. Colorectal cancer is cancer that starts in the large intestine (Colorectal). There is no single cause of colorectal cancer. Nearly all colorectal cancers begin as noncancerous (benign) polyps, which slowly develop into cancer. For More on Colorectal Cancer Pipeline Review H1 2017 Report Inquire @ https://goo.gl/1HQ4Fn . Report Description: Pharmaceutical guide Colorectal Cancer - Pipeline Review H1โ€ฆ
US Colorectal Cancer Drug Pipeline Analysis
Among all the regions affected with colorectal cancer, the US would continue to account for a giantโ€™s share owing to its huge population base. With regards to rates of increase, it is most likely that the US would witness a modest increase in the prevalence of the disease, mostly as a result of the country having already reached epidemic proportions of the disease. According to estimates, approximately 55,000 people dieโ€ฆ
Colorectal Cancer - Heat Map and Analysis
ReportsWorldwide has announced the addition of a new report title Colorectal Cancer - Heat Map and Analysis to its growing collection of premium market research reports. Colorectal cancer (CRC), otherwise known as bowel cancer, is a malignancy originating in the colon (the large intestine) or rectum, both of which are located towards the end of the human gastrointestinal tract. It begins as a benign tumor, which is almost always inโ€ฆ
Colorectal Cancer Treatment Market- Global Outlook 2024
Colorectal cancer is cancer that starts in the colon or rectum. The colon and the rectum are parts of the large intestine, which is the lower part of the bodyโ€™s digestive system. The colon absorbs water and nutrients from the food and stores waste matter (stool). Stool moves from the colon into the rectum before it leaves the body. Colorectal cancer often begins as a growth called a polyp, whichโ€ฆ